Skip to main content

Table 1 Patients’ characteristics and outcomes

From: Contrast-enhanced ultrasonography to evaluate changes in renal cortical microcirculation induced by noradrenaline: a pilot study

  On ICU admission At the time of CEUS study Outcomes
Patient number Age, years Main diagnosis Chronic kidney disease Diabetes Hypertension APACHE-III score Mechanical ventilation RIFLE NA dosage (μg/minute) Time on NA (hrs) Other inotropes ACE Inh < 48 h Diuretics < 48 hrs ICU LOS, days RIFLE RRT Death
1 51 Septic shock No No No 65 Yes R 13 46 Milrinone No No 6 F No No
2 64 Septic shock No Yes No 47 No - 6 20 No Yes Yes 5 R No No
3 30 Septic shock No No No 18 Yes - 3.5 6 No No No 4 I No No
4 71 Septic shock No No No 57 No R 4 26 No No No 2 I No No
5 84 Septic shock No No Yes 73 Yes R 14 52 No No Yes 10 R No Yes
6 42 Status epilepticus No No No 24 Yes R 10 48 No No Yes 12 R No No
7 68 Septic shock No Yes Yes 60 No - 2 17 No No No 3 - No No
8 63 Septic shock No No No 61 Yes I 15 19 No No No 4 I No No
9 32 Septic shock No No No 56 No - 11 5 No No No 2 R No No
10 71 Septic shock No No Yes 44 No F 10 21 No No No 2 F No Yes
11 62 Septic shock No No No 80 No I 16 8 Vasopressin No No 7 I No No
12 65 Cardiogenic shock No No No 75 Yes - 8 16 No No Yes 4 - No No
  1. APACHE, acute physiology and chronic health evaluation; NA, noradrenaline; RIFLE, risk, injury, failure, loss, end-stage kidney failure; ACE Inh, angiotensin converting enzyme inhibitors; LOS, length of stay; RRT, renal replacement therapy.